Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
… in patients with type 2 diabetes. The combinatory use of different anti-diabetic agents with … All seven RCTs were double-blinded and were therefore classified as low risk. For …..... Read More